Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bara

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Thrombosis Research|March 15, 1986
Bovine or human thrombin in amidolytic at III assays. Influence of heparin cofactor IIJ Conard, L Bara, M H Horellou, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[Lipolytic and anticoagulant activities of heparin and one of its low molecular weight derivatives]F Millot, L Bara, J Etienne, et al.
Thrombosis Research|September 1, 1994
Plasma TFPI activity after intravenous injection of pentasaccharide (PS) and unfractionated heparin in rabbitsD Zitoun, L Bara, M F Bloch, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 26, 1998
Comparative time course of thrombolysis induced by intravenous boluses and infusion of staphylokinase and tissue plasminogen activator in a rabbit arterial thrombosis modelG Helft, L Bara, M F Bloch, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1985
Amidolytic antifactor Xa assays in the laboratory evaluation of heparin and low molecular weight fractionsJ M Walenga, L Bara, M M Samama, et al.
Haemostasis|March 1, 1993
Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhageA Leizorovicz, L Bara, M M Samama, et al.
Thrombosis Research|September 1, 1985
Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administrationL Bara, E Billaud, G Gramond, et al.
Thrombosis and Haemostasis|April 1, 1994
Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIC and PAI-1 in European offspring--the EARS study. European Atherosclerosis Research Study GroupL Bara, V Nicaud, L Tiret, et al.
Haemostasis|January 1, 1987
Laboratory monitoring of a low molecular weight heparin (enoxaparin) with a new clotting test (Heptest)L Bara, S Combe-Tamzali, J Conard, et al.
Journal Des Maladies Vasculaires|January 1, 1987
[Biological modifications induced by 3 low molecular weight heparins, PK 10169, Kabi 2165 and CY 216, compared to unfractionated heparin injected subcutaneously in healthy subjects in general surgery and in aged subjects in internal medicine]L Bara, S Combe-Tamzali, J Conard, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Thrombosis Research|March 15, 1986
Bovine or human thrombin in amidolytic at III assays. Influence of heparin cofactor IIJ Conard, L Bara, M H Horellou, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1987
[Lipolytic and anticoagulant activities of heparin and one of its low molecular weight derivatives]F Millot, L Bara, J Etienne, et al.
Thrombosis Research|September 1, 1994
Plasma TFPI activity after intravenous injection of pentasaccharide (PS) and unfractionated heparin in rabbitsD Zitoun, L Bara, M F Bloch, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 26, 1998
Comparative time course of thrombolysis induced by intravenous boluses and infusion of staphylokinase and tissue plasminogen activator in a rabbit arterial thrombosis modelG Helft, L Bara, M F Bloch, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1985
Amidolytic antifactor Xa assays in the laboratory evaluation of heparin and low molecular weight fractionsJ M Walenga, L Bara, M M Samama, et al.
Haemostasis|March 1, 1993
Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhageA Leizorovicz, L Bara, M M Samama, et al.
Thrombosis Research|September 1, 1985
Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administrationL Bara, E Billaud, G Gramond, et al.
Thrombosis and Haemostasis|April 1, 1994
Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIC and PAI-1 in European offspring--the EARS study. European Atherosclerosis Research Study GroupL Bara, V Nicaud, L Tiret, et al.
Haemostasis|January 1, 1987
Laboratory monitoring of a low molecular weight heparin (enoxaparin) with a new clotting test (Heptest)L Bara, S Combe-Tamzali, J Conard, et al.
Journal Des Maladies Vasculaires|January 1, 1987
[Biological modifications induced by 3 low molecular weight heparins, PK 10169, Kabi 2165 and CY 216, compared to unfractionated heparin injected subcutaneously in healthy subjects in general surgery and in aged subjects in internal medicine]L Bara, S Combe-Tamzali, J Conard, et al.
Pageof 9